TP53 and neoplasm: To clarify the p53 dependency of the prognostic effect of NEAT1, tumors were divided into two groups, wild-type p53 and mutated p53 (including homologous deletion) groups, and then, prognosis was analyzed in 18 cancer tissues that had sufficient sample numbers of both wild-type and mutated p53 tumor tissues.